Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 89 Lymphoma 58 Lymphoma, Large B-Cell, Diffuse 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 33 Sarcoma 31 Lymphoma, Non-Hodgkin 27 Hodgkin Disease 23 Leukemia 20 Burkitt Lymphoma 20 Lymphoma, Mantle-Cell 18 Neoplasms 16 Triple Negative Breast Neoplasms 14 Lymphoma, Follicular 14 Lymphoma, B-Cell 12 Carcinoma, Hepatocellular 12 Lymphoma, Large-Cell, Anaplastic 11 Neuroblastoma 10 Multiple Myeloma 10 Breast Neoplasms, Male 10 Neoplasm Metastasis 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Ovarian Neoplasms 8 Lymphoma, T-Cell, Peripheral 7 Lymphoma, T-Cell 7 Inflammatory Breast Neoplasms 7 Urinary Bladder Neoplasms 6 Osteosarcoma 6 Liposarcoma 6 Leiomyosarcoma 6 Fallopian Tube Neoplasms 6

Interventions

fludarabine phosphate 20 Mycophenolic Acid 15 Whole-Body Irradiation 14 Peripheral Blood Stem Cell Transplantation 11 Cyclophosphamide 11 Cyclosporine 10 Cyclosporins 8 fludarabine 7 Tacrolimus 7 Rituximab 7 Antilymphocyte Serum 7 Busulfan 6 Sirolimus 4 Melphalan 4 Methotrexate 3 Cytarabine 3 Cord Blood Stem Cell Transplantation 3 pegfilgrastim 2 ibrutinib 2 Thiotepa 2 Oxaliplatin 2 Filgrastim 2 Etoposide 2 Darbepoetin alfa 2 thymoglobulin 1 selinexor 1 ofatumumab 1 immunotoxin HA22 1 ferrous sulfate 1 ferric gluconate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡